2013-04-01
Precancerous lesions in the stomach: From biology to clinical patient management
Publication
Publication
Best Practice and Research in Clinical Gastroenterology , Volume 27 - Issue 2 p. 205- 223
Gastric cancer is the final step in a multi-stage cascade triggered by long-standing inflammatory conditions (particularly Helicobacter pylori infection) resulting in atrophic gastritis and intestinal metaplasia: these lesions represent the cancerization field in which (intestinal-type) gastric cancer develops. Intraepithelial neoplasia is consistently recognized as the phenotypic bridge between atrophic/metaplastic lesions and invasive cancer. This paper addresses the epidemiology, pathology, molecular profiling, and clinical management of advanced precancerous gastric lesions.
Additional Metadata | |
---|---|
, , , | |
doi.org/10.1016/j.bpg.2012.12.007, hdl.handle.net/1765/40803 | |
Best Practice and Research in Clinical Gastroenterology | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Rugge, M., Capelle, L., Cappellesso, R., Nitti, D., & Kuipers, E. (2013). Precancerous lesions in the stomach: From biology to clinical patient management. Best Practice and Research in Clinical Gastroenterology, 27(2), 205–223. doi:10.1016/j.bpg.2012.12.007 |